8-K/A

AMENDED CURRENT REPORT

Company: TENAX THERAPEUTICS, INC.
Filed: March 30, 2021
Period of Report: January 15, 2021
Accession Number: 0001654954-21-003529

View Document ↗ View on SEC.gov ↗